These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Covid-19: Chinese vaccines may need changes to improve efficacy, admits official. Dyer O BMJ; 2021 Apr; 373():n969. PubMed ID: 33849893 [No Abstract] [Full Text] [Related]
44. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine. Dal-Ré R; Caplan AL; Gluud C; Porcher R Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636 [TBL] [Abstract][Full Text] [Related]
45. Running with the devil: race against COVID-19. Memo C J Wound Care; 2021 Jan; 30(1):7-8. PubMed ID: 33439088 [No Abstract] [Full Text] [Related]
46. Enrolling Minors in COVID-19 Vaccine Trials. Mintz K; Jardas E; Shah S; Grady C; Danis M; Wendler D Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33334920 [TBL] [Abstract][Full Text] [Related]
47. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark. Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115 [TBL] [Abstract][Full Text] [Related]
48. "When Will Bloom BR; Nowak GJ; Orenstein W N Engl J Med; 2020 Dec; 383(23):2202-2204. PubMed ID: 32897660 [No Abstract] [Full Text] [Related]
50. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281 [TBL] [Abstract][Full Text] [Related]
51. COVID-19 vaccination in our transplant recipients: The time is now. Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534 [TBL] [Abstract][Full Text] [Related]
52. Ethical allocation of COVID-19 vaccine in the United States: an evaluation of competing frameworks for the current pandemic and future events. Lawrence C; Vick DJ; Maryon T; Kerr BJ J Public Health Policy; 2022 Jun; 43(2):234-250. PubMed ID: 35140363 [TBL] [Abstract][Full Text] [Related]
53. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand? Al-Kassmy J; Pedersen J; Kobinger G Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685 [TBL] [Abstract][Full Text] [Related]
54. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Sharma O; Sultan AA; Ding H; Triggle CR Front Immunol; 2020; 11():585354. PubMed ID: 33163000 [TBL] [Abstract][Full Text] [Related]
55. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know. Rasmussen SA; Kelley CF; Horton JP; Jamieson DJ Obstet Gynecol; 2021 Mar; 137(3):408-414. PubMed ID: 33370015 [TBL] [Abstract][Full Text] [Related]
56. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related]
57. Ethical guidelines for deliberately infecting volunteers with COVID-19. Richards AD J Med Ethics; 2020 Aug; 46(8):502-504. PubMed ID: 32461245 [TBL] [Abstract][Full Text] [Related]
58. [SARS-CoV-2 vaccines - what the nephrologist should know]. Heine GH; Becker SL; Scheuer AL; Schirmer SH Dtsch Med Wochenschr; 2021 Apr; 146(7):466-470. PubMed ID: 33780993 [TBL] [Abstract][Full Text] [Related]
59. Clinical trials and the COVID-19 pandemic. Retsas S Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715 [TBL] [Abstract][Full Text] [Related]
60. An intersectional human rights approach to prioritising access to COVID-19 vaccines. Sekalala S; Perehudoff K; Parker M; Forman L; Rawson B; Smith M BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33627362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]